OMEROS CORP Comprehensive Income
OMEROS CORP (OMER) reported Comprehensive Income of -$22.70 million for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-09.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2021-11-09
- OMEROS CORP comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2021-09-30 was -$22.70M.
- OMEROS CORP comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2021-06-30 was -$28.59M.
- OMEROS CORP comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2021-03-31 was -$35.09M.
- OMEROS CORP comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2020-12-31 was -$37.27M.
- OMEROS CORP comprehensive income (loss), net of tax, attributable to parent for fiscal 2020 was -$138.06M.
- OMEROS CORP comprehensive income (loss), net of tax, attributable to parent for fiscal 2019 was -$84.49M.
- OMEROS CORP comprehensive income (loss), net of tax, attributable to parent for fiscal 2018 was -$126.76M.
- OMEROS CORP comprehensive income (loss), net of tax, attributable to parent for fiscal 2017 was -$53.48M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2021-09-30 | -$22.70M 10-Q · filed 2021-11-09 | -$51.30M derived: sum of 2 quarters · filed 2021-11-09 | -$86.39M 10-Q · filed 2021-11-09 | -$123.66M derived: sum of 4 quarters · filed 2021-11-09 |
| 2021-06-30 | -$28.59M 10-Q · filed 2021-08-09 | -$63.68M 10-Q · filed 2021-08-09 | -$100.96M derived: sum of 3 quarters · filed 2021-08-09 | -$139.42M derived: sum of 4 quarters · filed 2021-11-09 |
| 2021-03-31 | -$35.09M 10-Q · filed 2021-05-10 | -$72.36M derived: sum of 2 quarters · filed 2021-05-10 | -$110.83M derived: sum of 3 quarters · filed 2021-11-09 | -$144.12M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-12-31 | -$37.27M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$75.74M derived: sum of 2 quarters · filed 2021-11-09 | -$109.03M derived: sum of 3 quarters · filed 2021-11-09 | -$138.06M 10-K · filed 2021-03-01 |
| 2020-09-30 | -$38.46M 10-Q · filed 2021-11-09 | -$71.76M derived: sum of 2 quarters · filed 2021-11-09 | -$100.79M 10-Q · filed 2021-11-09 | -$130.01M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | -$33.29M 10-Q · filed 2021-08-09 | -$62.33M 10-Q · filed 2021-08-09 | -$91.55M derived: sum of 3 quarters · filed 2021-08-09 | -$108.01M derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | -$29.03M 10-Q · filed 2021-05-10 | -$58.26M derived: sum of 2 quarters · filed 2021-05-10 | -$74.72M derived: sum of 3 quarters · filed 2021-05-10 | -$89.17M derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | -$29.23M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$45.69M derived: sum of 2 quarters · filed 2021-03-01 | -$60.14M derived: sum of 3 quarters · filed 2021-03-01 | -$84.49M 10-K · filed 2021-03-01 |
| 2019-09-30 | -$16.46M 10-Q · filed 2020-11-09 | -$30.92M derived: sum of 2 quarters · filed 2020-11-09 | -$55.26M 10-Q · filed 2020-11-09 | -$78.80M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | -$14.45M 10-Q · filed 2020-08-10 | -$38.80M 10-Q · filed 2020-08-10 | -$62.33M derived: sum of 3 quarters · filed 2021-03-01 | -$101.80M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | -$24.34M 10-Q · filed 2020-05-11 | -$47.88M derived: sum of 2 quarters · filed 2021-03-01 | -$87.35M derived: sum of 3 quarters · filed 2021-03-01 | -$121.05M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | -$23.53M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$63.01M derived: sum of 2 quarters · filed 2021-03-01 | -$96.70M derived: sum of 3 quarters · filed 2021-03-01 | -$126.76M 10-K · filed 2021-03-01 |
| 2018-09-30 | -$39.47M 10-Q · filed 2019-11-12 | -$73.17M derived: sum of 2 quarters · filed 2019-11-12 | -$103.22M 10-Q · filed 2019-11-12 | -$119.77M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | -$33.70M 10-Q · filed 2019-08-08 | -$63.75M 10-Q · filed 2019-08-08 | -$80.30M derived: sum of 3 quarters · filed 2020-03-02 | -$87.78M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | -$30.05M 10-Q · filed 2019-05-09 | -$46.60M derived: sum of 2 quarters · filed 2020-03-02 | -$54.09M derived: sum of 3 quarters · filed 2020-03-02 | -$68.45M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | -$16.55M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$24.03M derived: sum of 2 quarters · filed 2020-03-02 | -$38.39M derived: sum of 3 quarters · filed 2020-03-02 | -$53.48M 10-K · filed 2020-03-02 |
| 2017-09-30 | -$7.48M 10-Q · filed 2018-11-08 | -$21.84M derived: sum of 2 quarters · filed 2018-11-08 | -$36.93M 10-Q · filed 2018-11-08 | -$56.56M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | -$14.36M 10-Q · filed 2018-08-09 | -$29.45M 10-Q · filed 2018-08-09 | -$49.08M derived: sum of 3 quarters · filed 2019-03-01 | -$63.04M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | -$15.09M 10-Q · filed 2018-05-10 | -$34.72M derived: sum of 2 quarters · filed 2019-03-01 | -$48.68M derived: sum of 3 quarters · filed 2019-03-01 | -$61.30M derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | -$19.63M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$33.59M derived: sum of 2 quarters · filed 2019-03-01 | -$46.21M derived: sum of 3 quarters · filed 2019-03-01 | -$66.75M 10-K · filed 2019-03-01 |
| 2016-09-30 | -$13.96M 10-Q · filed 2017-11-09 | -$26.57M derived: sum of 2 quarters · filed 2017-11-09 | -$47.11M 10-Q · filed 2017-11-09 | -$66.94M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | -$12.61M 10-Q · filed 2017-08-08 | -$33.15M 10-Q · filed 2017-08-08 | -$52.98M derived: sum of 3 quarters · filed 2018-03-01 | -$72.90M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | -$20.54M 10-Q · filed 2017-05-10 | -$40.37M derived: sum of 2 quarters · filed 2018-03-01 | -$60.29M derived: sum of 3 quarters · filed 2018-03-01 | -$76.97M derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | -$19.83M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$39.75M derived: sum of 2 quarters · filed 2018-03-01 | -$56.43M derived: sum of 3 quarters · filed 2018-03-01 | -$75.10M 10-K · filed 2018-03-01 |
| 2015-09-30 | -$19.92M 10-Q · filed 2016-11-09 | -$36.60M derived: sum of 2 quarters · filed 2016-11-09 | -$55.27M 10-Q · filed 2016-11-09 | -$75.98M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | -$16.68M 10-Q · filed 2016-08-09 | -$35.35M 10-Q · filed 2016-08-09 | -$56.06M derived: sum of 3 quarters · filed 2017-03-16 | -$74.39M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | -$18.67M 10-Q · filed 2016-05-10 | -$39.38M derived: sum of 2 quarters · filed 2017-03-16 | -$57.71M derived: sum of 3 quarters · filed 2017-03-16 | -$75.70M derived: sum of 4 quarters · filed 2017-03-16 |
| 2014-12-31 | -$20.71M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$39.04M derived: sum of 2 quarters · filed 2017-03-16 | -$57.03M derived: sum of 3 quarters · filed 2017-03-16 | -$73.67M 10-K · filed 2017-03-16 |
| 2014-09-30 | -$18.33M 10-Q · filed 2015-11-09 | -$36.32M derived: sum of 2 quarters · filed 2015-11-09 | -$52.96M 10-Q · filed 2015-11-09 | -$54.80M derived: sum of 4 quarters · filed 2016-03-15 |
| 2014-06-30 | -$17.99M 10-Q · filed 2015-08-10 | -$34.63M 10-Q · filed 2015-08-10 | -$36.48M derived: sum of 3 quarters · filed 2016-03-15 | -$50.35M derived: sum of 4 quarters · filed 2016-03-15 |
| 2014-03-31 | -$16.64M 10-Q · filed 2015-05-11 | -$18.49M derived: sum of 2 quarters · filed 2016-03-15 | -$32.36M derived: sum of 3 quarters · filed 2016-03-15 | -$45.95M derived: sum of 4 quarters · filed 2016-03-15 |
| 2013-12-31 | -$1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | -$15.71M derived: sum of 2 quarters · filed 2016-03-15 | -$29.31M derived: sum of 3 quarters · filed 2016-03-15 | -$39.80M 10-K · filed 2016-03-15 |
| 2013-09-30 | -$13.87M 10-Q · filed 2014-11-10 | -$27.46M derived: sum of 2 quarters · filed 2014-11-10 | -$37.95M 10-Q · filed 2014-11-10 | -$45.69M derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-06-30 | -$13.59M 10-Q · filed 2014-08-11 | -$24.08M 10-Q · filed 2014-08-11 | -$31.82M derived: sum of 3 quarters · filed 2015-03-16 | -$45.09M derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-03-31 | -$10.49M 10-Q · filed 2014-05-12 | -$18.22M derived: sum of 2 quarters · filed 2015-03-16 | -$31.50M derived: sum of 3 quarters · filed 2015-03-16 | -$40.04M derived: sum of 4 quarters · filed 2015-03-16 |
| 2012-12-31 | -$7.73M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | -$21.01M derived: sum of 2 quarters · filed 2015-03-16 | -$29.55M derived: sum of 3 quarters · filed 2015-03-16 | -$38.44M 10-K · filed 2015-03-16 |
| 2012-09-30 | -$13.28M 10-Q · filed 2013-11-07 | -$21.82M derived: sum of 2 quarters · filed 2013-11-07 | -$30.71M 10-Q · filed 2013-11-07 | -$40.91M derived: sum of 4 quarters · filed 2014-03-13 |
| 2012-06-30 | -$8.54M 10-Q · filed 2013-08-09 | -$17.43M 10-Q · filed 2013-08-09 | -$27.64M derived: sum of 3 quarters · filed 2014-03-13 | -$34.15M derived: sum of 4 quarters · filed 2014-03-13 |
| 2012-03-31 | -$8.89M 10-Q · filed 2013-05-09 | -$19.10M derived: sum of 2 quarters · filed 2014-03-13 | -$25.61M derived: sum of 3 quarters · filed 2014-03-13 | -$30.90M derived: sum of 4 quarters · filed 2014-03-13 |
| 2011-12-31 | -$10.20M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | -$16.71M derived: sum of 2 quarters · filed 2014-03-13 | -$22.00M derived: sum of 3 quarters · filed 2014-03-13 | -$28.55M 10-K · filed 2014-03-13 |
| 2011-09-30 | -$6.51M 10-Q · filed 2012-11-09 | -$11.80M derived: sum of 2 quarters · filed 2012-11-09 | -$18.34M 10-Q · filed 2012-11-09 | |
| 2011-06-30 | -$5.29M 10-Q · filed 2012-08-07 | -$11.83M 10-Q · filed 2012-08-07 | ||
| 2011-03-31 | -$6.54M 10-Q · filed 2012-05-10 | |||
| 2010-12-31 | -$29.29M 10-K · filed 2013-03-18 | |||
| 2009-12-31 | -$20.95M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |